Long non-coding RNAs in the failing heart and vasculature

Steffie Hermans-Beijnsberger; Marc van Bilsen; Blanche Schroen

doi:10.1016/j.ncrna.2018.04.002

Long non-coding RNAs in the failing heart and vasculature

Steffie Hermans-Beijnsberger, Marc van Bilsen, Blanche Schroen^*

^*Corresponding author for this work

Research output: Contribution to journal › (Systematic) Review article › peer-review

Abstract

Following completion of the human genome, it became evident that the majority of our DNA is transcribed into non-coding RNAs (ncRNAs) instead of protein-coding messenger RNA. Deciphering the function of these ncRNAs, including both small- and long ncRNAs (lncRNAs), is an emerging field of research. LncRNAs have been associated with many disorders and a number have been identified as key regulators in the development and progression of disease, including cardiovascular disease (CVD). CVD causes millions of deaths worldwide, annually. Risk factors include coronary artery disease, high blood pressure and ageing. In this review, we will focus on the roles of lncRNAs in the cellular and molecular processes that underlie the development of CVD: cardiomyocyte hypertrophy, fibrosis, inflammation, vascular disease and ageing. Finally, we discuss the biomarker and therapeutic potential of lncRNAs.

Original language	English
Pages (from-to)	118-130
Number of pages	13
Journal	Non-coding RNA research
Volume	3
Issue number	3
DOIs	https://doi.org/10.1016/j.ncrna.2018.04.002
Publication status	Published - Sept 2018

Access to Document

10.1016/j.ncrna.2018.04.002Licence: CC BY-NC-ND

Cite this

@article{250aa142d9ce44e8839a8d2f2c894fb5,

title = "Long non-coding RNAs in the failing heart and vasculature",

abstract = "Following completion of the human genome, it became evident that the majority of our DNA is transcribed into non-coding RNAs (ncRNAs) instead of protein-coding messenger RNA. Deciphering the function of these ncRNAs, including both small- and long ncRNAs (lncRNAs), is an emerging field of research. LncRNAs have been associated with many disorders and a number have been identified as key regulators in the development and progression of disease, including cardiovascular disease (CVD). CVD causes millions of deaths worldwide, annually. Risk factors include coronary artery disease, high blood pressure and ageing. In this review, we will focus on the roles of lncRNAs in the cellular and molecular processes that underlie the development of CVD: cardiomyocyte hypertrophy, fibrosis, inflammation, vascular disease and ageing. Finally, we discuss the biomarker and therapeutic potential of lncRNAs.",

author = "Steffie Hermans-Beijnsberger and {van Bilsen}, Marc and Blanche Schroen",

year = "2018",

month = sep,

doi = "10.1016/j.ncrna.2018.04.002",

language = "English",

volume = "3",

pages = "118--130",

journal = "Non-coding RNA research",

issn = "2468-0540",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "3",

}

TY - JOUR

T1 - Long non-coding RNAs in the failing heart and vasculature

AU - Hermans-Beijnsberger, Steffie

AU - van Bilsen, Marc

AU - Schroen, Blanche

PY - 2018/9

Y1 - 2018/9

N2 - Following completion of the human genome, it became evident that the majority of our DNA is transcribed into non-coding RNAs (ncRNAs) instead of protein-coding messenger RNA. Deciphering the function of these ncRNAs, including both small- and long ncRNAs (lncRNAs), is an emerging field of research. LncRNAs have been associated with many disorders and a number have been identified as key regulators in the development and progression of disease, including cardiovascular disease (CVD). CVD causes millions of deaths worldwide, annually. Risk factors include coronary artery disease, high blood pressure and ageing. In this review, we will focus on the roles of lncRNAs in the cellular and molecular processes that underlie the development of CVD: cardiomyocyte hypertrophy, fibrosis, inflammation, vascular disease and ageing. Finally, we discuss the biomarker and therapeutic potential of lncRNAs.

AB - Following completion of the human genome, it became evident that the majority of our DNA is transcribed into non-coding RNAs (ncRNAs) instead of protein-coding messenger RNA. Deciphering the function of these ncRNAs, including both small- and long ncRNAs (lncRNAs), is an emerging field of research. LncRNAs have been associated with many disorders and a number have been identified as key regulators in the development and progression of disease, including cardiovascular disease (CVD). CVD causes millions of deaths worldwide, annually. Risk factors include coronary artery disease, high blood pressure and ageing. In this review, we will focus on the roles of lncRNAs in the cellular and molecular processes that underlie the development of CVD: cardiomyocyte hypertrophy, fibrosis, inflammation, vascular disease and ageing. Finally, we discuss the biomarker and therapeutic potential of lncRNAs.

U2 - 10.1016/j.ncrna.2018.04.002

DO - 10.1016/j.ncrna.2018.04.002

M3 - (Systematic) Review article

C2 - 30175285

SN - 2468-0540

VL - 3

SP - 118

EP - 130

JO - Non-coding RNA research

JF - Non-coding RNA research

IS - 3

ER -

Long non-coding RNAs in the failing heart and vasculature

Abstract

Access to Document

Fingerprint

Cite this